Aktie A0M3UM HPGC RENMINTONGTAI PHARMACEUTICAL CORPORATION
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen HPGC Renmintongtai Pharmaceutical Corporation

Aktien

A0M3UM

CNE000000G05

600829

Schlusskurs Shanghai S.E.
Andere Börsenplätze
 00:00:00 28.06.2024 		% 5 Tage % 1. Jan.
5.61 CNY +0.90% Intraday Chart für HPGC Renmintongtai Pharmaceutical Corporation 0.00% -28.26%
19.04. HPGC Renmintongtai Pharmaceutical Corporation meldet Ergebnis für das erste Quartal bis zum 31. März 2024 CI
27.03. HPGC Renmintongtai Pharmaceutical Corporation berichtet über die Ergebnisse für das am 31. Dezember 2023 endende Geschäftsjahr CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
HPGC Renmintongtai Pharmaceutical Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024
HPGC Renmintongtai Pharmaceutical Corporation Reports Earnings Results for the Full Year Ended December 31, 2023
HPGC Renmintongtai Chairman Steps Down; Successor Named
HPGC Renmintongtai Pharmaceutical Corporation Reports Earnings Results for the Nine Months Ended September 30, 2023
HPGC Renmintongtai Pharmaceutical Corporation Reports Earnings Results for the Half Year Ended June 30, 2023
HPGC Renmintongtai Pharmaceutical Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023
HPGC Renmintongtai Pharmaceutical Corporation Reports Earnings Results for the Nine Months Ended September 30, 2022
HPGC Renmintongtai Pharmaceutical Corporation Reports Earnings Results for the Half Year Ended June 30, 2022
HPGC Renmintongtai Pharmaceutical Corporation Reports Earnings Results for the First Quarter Ended March 31, 2022
HPGC Renmintongtai Pharmaceutical Corporation Reports Earnings Results for the Full Year Ended December 31, 2021
Hpgc Renmintongtai Pharmaceutical Corporation Reports Earnings Results for the Nine Months Ended September 30, 2021
Hpgc Renmintongtai Pharmaceutical Corporation Reports Earnings Results for the Half Year Ended June 30, 2021
Hpgc Renmintongtai Pharmaceutical Corporation Reports Earnings Results for the First Quarter Ended March 31, 2021
Hpgc Renmintongtai Pharmaceutical Corporation Reports Earnings Results for the Full Year Ended December 31, 2020
Hpgc Renmintongtai Pharmaceutical Corporation Reports Earnings Results for the Nine Months Ended September 30, 2020
Hpgc Renmintongtai Pharmaceutical Corporation Reports Earnings Results for the Half Year Ended June 30, 2020
Hpgc Renmintongtai Pharmaceutical Corporation Reports Earnings Results for the First Quarter Ended March 31, 2020
Hpgc Renmintongtai Pharmaceutical Corporation Reports Earnings Results for the Full Year Ended December 31, 2019
HPGC Renmintongtai Pharmaceutical Corporation Approves Amending of Articles of Association
HPGC Renmintongtai Pharmaceutical Corporation announced that it has received funding from Harbin Pharmaceutical Group Co., Ltd.
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A0M3UM Aktie
  4. Nachrichten HPGC Renmintongtai Pharmaceutical Corporation
  5. Andere Sprachen